Aging is an inevitable process that affects everyone. As we age, the risk of developing chronic diseases increases, and our bodies become less efficient at repairing themselves. However, recent studies have shown that low doses of melatonin can help slow down the progression of aging. In this article, we will explore the role of melatonin in aging and its effects on the body.
What is Melatonin?
Melatonin is a hormone that is naturally produced in the pineal gland located in the brain. This hormone regulates the sleep-wake cycle and is responsible for the body’s internal clock. Melatonin levels in the body increase at night, making us feel sleepy, and decrease during the day, making us feel awake.
Melatonin’s Role in Slowing Aging
As we age, the production of melatonin decreases, leading to altered sleep patterns and other age-related changes. Studies have shown that low doses of melatonin can help slow down the progression of aging by improving sleep quality, reducing inflammation, and protecting against oxidative stress.
Improving Sleep Quality
Melatonin supplementation has been shown to improve sleep quality in older adults, leading to better cognitive function, improved mood, and overall better health. As we age, the quality of our sleep decreases, leading to disrupted sleep patterns and frequent awakenings. Melatonin helps regulate the body’s internal clock, which can improve sleep quality.
Reducing Inflammation
Inflammation is a natural response of the body to injury or infection. However, chronic inflammation can lead to the development of chronic diseases such as heart disease, diabetes, and cancer. Melatonin has been shown to reduce inflammation in the body, leading to a reduced risk of developing chronic diseases.
Studies have shown that melatonin can reduce inflammation by inhibiting the production of pro-inflammatory cytokines and chemokines. These molecules play a key role in the development of chronic inflammation, and melatonin can help reduce their levels in the body.
Protecting Against Oxidative Stress
Oxidative stress occurs when there is an imbalance between free radicals and antioxidants in the body. This imbalance can lead to cell damage and the development of chronic diseases. Melatonin has been shown to act as an antioxidant, protecting against oxidative stress and reducing the risk of developing chronic diseases.
Melatonin acts as an antioxidant by scavenging free radicals in the body. Free radicals are unstable molecules that can damage cells and lead to the development of chronic diseases. Melatonin helps neutralize these free radicals, reducing the risk of cell damage and chronic disease.
Recommended Dosages and Frequency
The recommended dosage of melatonin varies depending on the individual’s age and sleep patterns. For older adults, a low dose of 300mcg to 500mcg is recommended, taken 30 minutes before bedtime. It is important to note that melatonin should not be taken during the day as it can cause drowsiness.
Conclusion
In conclusion, low doses of melatonin can help slow down the progression of aging by improving sleep quality, reducing inflammation, and protecting against oxidative stress. If you are an older adult looking to improve your overall health and well-being, consider adding a low dose of melatonin to your nightly routine.
Recommended Supplements
Disclaimer: This article is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult with your physician before taking any supplements.
Disclosure: This article contains Amazon affiliate links to 300mcg melatonin supplements. As an Amazon Associate, we earn from qualifying purchases.
Sources
- Pandi-Perumal, S. R., Smits, M. G., Spence, D. W., & Cardinali, D. P. (2007). Melatonin and aging: Prospects for human treatment. Journal of aging research, 2007.
- Cardinali, D. P., Vigo, D. E., & Olivar, N. (2012). Melatonin therapy in aging and age-related diseases. Annals of the New York Academy of Sciences, 1261(1), 66-72.
- Perras, B., Kurowski, V., & Dodt, C. (2009). Nocturnal melatonin secretion and sleep after doxepin administration in elder insomniacs. Journal of Pineal Research, 47(1), 17-25.
- Hardeland, R., Pandi-Perumal, S. R., & Cardinali, D. P. (2006). Melatonin. International journal of biochemistry & cell biology, 38(3), 313-316.
- Reiter, R. J., Tan, D. X., & Galano, A. (2014). Melatonin: exceeding expectations. Physiology, 29(5), 325-333.
longevityvault.com 